Tiotropium Bromide
Brand name: Spiriva Handihaler
Rank #39 of 500 drugs by total cost
$478.1M
Total Cost
673,800
Total Claims
$478.1M
Total Cost
25,545
Prescribers
$710
Cost per Claim
75,865
Beneficiaries
962,918
30-Day Fills
$19K
Avg Cost/Provider
26
Avg Claims/Provider
About Tiotropium Bromide
Tiotropium Bromide (sold as Spiriva Handihaler) was prescribed 673,800 times by 25,545 Medicare Part D providers in 2023, costing the program $478.1M. At $710 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 36 | Varicella-Zoster Ge/As01b/Pf (Shingrix) | $514.4M | 2,419,884 |
| 37 | Tafamidis (Vyndamax) | $511.1M | 20,589 |
| 38 | Fluticasone/Vilanterol (Breo Ellipta) | $493.0M | 909,837 |
| 39 | Tiotropium Bromide (Spiriva Handihaler) | $478.1M | 673,800 |
| 40 | Evolocumab (Repatha Sureclick) | $460.5M | 528,560 |
| 41 | Acalabrutinib Maleate (Calquence) | $457.0M | 31,890 |
| 42 | Atorvastatin Calcium (Atorvastatin Calcium) | $444.6M | 30,263,929 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology